查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2000735

安全針市場：全球市場按產品類型、材料、分銷管道、應用和最終用戶分類的預測 - 2026-2032 年

Safety Needles Market by Product Type, Material, Distribution Channel, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，安全針市場價值將達到 66.7 億美元，到 2026 年將成長至 72.5 億美元，到 2032 年將達到 119.5 億美元，複合年成長率為 8.67%。

主要市場統計數據
基準年 2025 66.7億美元
預計年份：2026年 72.5億美元
預測年份 2032 119.5億美元
複合年成長率 (%) 8.67%

臨床安全優先事項、監管期望和採購政策如何重塑安全針頭的引進和策略採購，其根本背景為何？

安全針頭產業處於病患安全、醫療服務流程和全球供應鏈韌性的關鍵交匯點。近年來，隨著監管機構對預防事故的日益重視、門診和居家照護場所的擴張，以及醫護人員和患者安全期望的不斷提高，安全針頭已從一種小眾的臨床選擇躍升為採購的核心優先事項。本文旨在探討影響製造、分銷和臨床應用等各個環節採購行為、創新重點和競爭動態的根本因素。

臨床使用者的需求、供應鏈韌性的壓力以及產品創新如何從根本上改變安全針頭的開發和採購？

安全針市場格局正經歷一場變革，其驅動力來自臨床、技術和供應方面的多重趨勢。臨床醫師越來越重視人因工程和實證安全結果，單手操作、觸覺回饋和穩定的防護性能等設計特性已成為關鍵的選擇標準。同時，製造商也正在加速產品現代化，採用更簡單的操作機制和材料，確保產品在各種醫療環境中都能可靠運作。

全面概述 2025 年美國關稅調整將如何重塑整個價值鏈中的採購決策、製造地和相關人員成本趨勢。

2025年美國關稅政策的變化將對整個安全針俱生態系統中的相關人員產生連鎖的營運和戰略影響。對進口原料、零件或成品徵收關稅將增加依賴進口的製造商和經銷商的總進口成本，從而影響採購決策和合約談判。對於擁有國際供應鏈的公司而言，重新評估供應商所在地和總到貨成本迫在眉睫，這需要對關稅風險、關稅分類機會以及潛在的風險緩解措施（例如關稅工程和替代原料）進行更詳細的分析。

基於細分的詳細洞察，揭示產品類型、材料、應用、最終用戶和分銷管道如何相互作用並影響採用和採購結果。

本市場分析依產品類型將產品分為兩大類：「主動式」和「被動式」。每類產品都有其獨特的運作機制和使用者互動方式，這會影響其臨床應用模式。同時，根據材料成分，市場又分為「金屬」和「塑膠」兩類。材料的選擇會影響產品的耐用性、滅菌相容性、製造成本結構和可回收性，而這些因素在採購評估中變得越來越重要。

一份策略性區域分析報告，闡述了美洲、歐洲、中東和非洲以及亞太市場的監管、採購和採用促進因素有何不同。

區域趨勢在塑造安全針頭市場的監管預期、採購行為和創新應用方面發揮著至關重要的作用。在美洲，醫療保健系統擁有完善的組織採購架構和強力的臨床管治，優先採購那些具有明確且可證實的安全優勢並符合感染預防方案的醫療器材。採購週期會受到公共衛生舉措和支付方審查的影響，供應商通常需要提供可靠的臨床數據才能獲得大規模機構合約。

對決定安全針創新和供應可靠性主導主要企業的競爭動態、戰略夥伴關係和能力優先事項進行了深入分析。

安全針頭產業的競爭動態凸顯了產品持續改進、合規性和一體化服務的重要性。市場參與企業優先投資於人因工程測試和臨床證據的積累，以在採購過程中脫穎而出，因為可驗證的結果和安全性聲明備受重視。製造商與臨床合作夥伴之間的合作日益加強，共同開發先導計畫和真實世界證據研究有助於加快產品在臨床相關人員中的接受度。

為製造商、經銷商和採購經理提供切實可行的高優先級建議，以加快安全針頭產業的採用、降低風險並增強競爭優勢。

產業領導者應採取多管齊下的策略方法，將產品開發、供應鏈韌性和商業性合作結合，以掌握新的機會。首先，在開發週期的早期階段，應優先考慮人體工學和嚴格的臨床檢驗，以開發出既能切實降低針刺風險，又能方便各類使用者使用的設備。投資臨床研究和真實世界證據將顯著加強採購對話，並加速醫療機構和社區對相關產品的採用。

為了支持本報告的發現和結論，我們將詳細描述混合方法研究途徑，該方法結合了初步訪談、文件分析和檢驗。

本調查方法結合一手和二手資料收集、結構化專家訪談以及交叉檢驗技術，確保獲得可靠且可操作的見解。一手研究包括對臨床醫生、採購負責人和供應鏈高管的訪談，以收集關於醫療設備性能、採購標準和供應連續性挑戰的第一手觀點。這些定性資料用於產生假設，並制定有針對性的後續問題以檢驗新的主題。

簡潔地總結了關鍵發現，這些發現將臨床、供應鏈和商業性影響與相關人員聯繫起來，以幫助他們了解不斷變化的安全針頭領域。

總之，安全針頭的市場格局正受到臨床優先事項、監管、不斷變化的經銷管道和供應鏈重組等因素的共同影響而重塑。隨著醫療模式日益分散化和以患者為中心的醫療服務模式的擴展，那些兼具可靠安全機制、以用戶為中心的設計以及經臨床驗證的療效的醫療設備將獲得採購和臨床利益相關人員的鼎力支持。同時，關稅調整和地緣政治發展等外部因素也在推動企業對製造地和籌資策略進行策略性重新評估。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：安全針市場：依產品類型分類

  • 活動類型
  • 被動的

第9章：安全針市場：依材料分類

  • 金屬
  • 塑膠

第10章：安全針市場：依分銷管道分類

  • 醫院藥房
  • 線上
    • 企業網站
    • 第三方平台
  • 零售藥房

第11章 安全針市場：依應用領域分類

  • 血液樣本
  • 胰島素給藥
  • 疫苗接種

第12章：安全針市場：依最終用戶分類

  • 診所
  • 居家照護
  • 醫院

第13章：安全針市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：安全針市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 安全針市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國安全針市場

第17章 中國安全針市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AdvaCare Pharma
  • Argon Medical Devices, Inc.
  • Artsana Group
  • B. Braun SE
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cartel Healthcare Pvt. Ltd.
  • Eli Lilly and Company
  • Gerresheimer AG
  • Hindustan Syringes and Medical Devices Ltd.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Nanchang Kindly（KDL）Medical Technology Co., Ltd.
  • Nipro Corporation
  • Novo Nordisk A/S
  • Retractable Technologies, Inc.
  • Retrago Technologies
  • Smiths Medical, Inc.
  • Socorex Isba SA
  • Sol-Millennium Medical Inc.
  • Terumo Europe NV
  • UltiMed, Inc.
Product Code: MRR-02026C4C9107

The Safety Needles Market was valued at USD 6.67 billion in 2025 and is projected to grow to USD 7.25 billion in 2026, with a CAGR of 8.67%, reaching USD 11.95 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.67 billion
Estimated Year [2026] USD 7.25 billion
Forecast Year [2032] USD 11.95 billion
CAGR (%) 8.67%

Foundational context on how clinical safety priorities, regulatory expectations, and procurement discipline are reshaping safety needle adoption and strategic sourcing

The safety needle sector occupies a critical intersection between patient safety, provider workflow, and global supply chain resilience. Over recent years, heightened regulatory attention on needlestick prevention, expanding outpatient and home-care settings, and rising expectations for clinician and patient safety have elevated safety needles from a niche clinical preference to a central procurement priority. This introduction establishes the contextual pillars that inform procurement behavior, innovation priorities, and competitive dynamics across manufacturing, distribution, and clinical adoption.

As stakeholders reevaluate product specifications and sourcing strategies, factors such as device ergonomics, activation reliability, and compatibility with existing clinical systems increasingly influence adoption decisions. Meanwhile, institutional purchasers and integrated delivery networks focus on lifecycle cost, staff training requirements, and post-market surveillance as part of broader patient-safety programs. At the same time, regulatory frameworks and guidance documents reinforce the need for demonstrable risk reduction and validated safety performance, prompting manufacturers to align development roadmaps with compliance pathways.

Taken together, these forces create a market environment where clinical evidence, supply continuity, and actionable total-cost perspectives determine which solutions gain traction. This introduction frames the rest of the executive summary by emphasizing how regulatory momentum, clinical priorities, and procurement discipline converge to shape near-term and medium-term choices for product development, sourcing, and distribution.

How converging clinical user needs, supply chain resilience pressures, and product innovation are driving fundamental changes in safety needle development and procurement

The landscape for safety needles is undergoing transformative shifts driven by converging clinical, technological, and supply-side dynamics. Clinicians are placing greater emphasis on human factors engineering and evidence-based safety outcomes, which has elevated design attributes such as single-handed activation, tactile feedback, and consistent shielding performance into primary selection criteria. At the same time, manufacturers are accelerating product modernization, integrating simpler activation mechanics and materials that support reliable function across varied care environments.

In parallel, care delivery is decentralizing; vaccination campaigns, chronic disease management, and insulin administration increasingly occur outside traditional inpatient settings. This transition amplifies demand for devices that are intuitive for non-clinician users, robust in home storage conditions, and compatible with community health workflows. Consequently, product roadmaps and marketing strategies have begun prioritizing usability testing with end users and expanded post-market data collection to demonstrate real-world safety benefits.

Supply chain pressure and procurement sophistication are catalyzing another wave of transformation. Buyers are seeking suppliers who can demonstrate not only product performance but also traceable manufacturing practices, resilient distribution channels, and responsive after-sales support. As a result, strategic partnerships, contract flexibility, and modular manufacturing approaches are becoming differentiators. Collectively, these shifts are redefining how value is created and measured across the safety needle ecosystem, moving the sector toward solutions that balance clinical efficacy, user-centered design, and operational resilience.

Comprehensive overview of how 2025 United States tariff adjustments are reshaping sourcing decisions, manufacturing footprints, and stakeholder cost dynamics across the value chain

United States tariff policy changes in 2025 have created a cascade of operational and strategic implications for stakeholders throughout the safety needle ecosystem. Tariffs on imported raw materials, component parts, or finished devices elevate landed costs for import-reliant manufacturers and distributors, which in turn influences sourcing decisions and contract negotiations. For companies with international supply chains, the need to reassess supplier footprints and total landed cost has become urgent, prompting deeper analysis of tariff exposure, tariff classification opportunities, and potential mitigation pathways such as tariff engineering or alternative inputs.

Moreover, tariffs can accelerate regionalization and nearshoring strategies. Firms that previously relied on low-cost overseas production may evaluate onshore or nearshore manufacturing alternatives to reduce tariff risk and improve supply continuity. While transition costs exist, organizations often find that improved lead times, lower inventory risk, and closer quality control offset near-term investment. Consequently, procurement teams are updating supplier scorecards to incorporate tariff sensitivity and geopolitical risk as explicit evaluative metrics.

Tariff changes also influence downstream stakeholders. Hospitals, clinics, and group purchasing organizations face revised procurement cycles as suppliers renegotiate pricing or revise contract terms. Payers and reimbursement entities may scrutinize cost increases and seek evidence that safety and quality benefits justify higher unit costs. Finally, regulatory compliance and customs classification accuracy have become higher priority activities, as incorrect classification can trigger retrospective duties or penalties. In response, cross-functional teams are strengthening collaboration among sourcing, legal, regulatory, and commercial functions to align mitigation strategies and maintain continuity of care delivery.

Deep segmentation-based insights revealing how product type, material, application, end user, and distribution channels converge to influence adoption and procurement outcomes

The market analysis segments product offerings by product type into two principal categories: Active and Passive devices, each with distinct activation mechanisms and user interaction profiles that influence clinical adoption patterns. In parallel, material composition divides the landscape into Metal and Plastic constructs, where material choice affects durability, sterilization compatibility, and manufacturing cost structures, as well as recyclability considerations that increasingly factor into procurement evaluations.

Application-focused segmentation highlights three core clinical uses: Blood Collection, Insulin Delivery, and Vaccination, each of which presents unique user requirements, throughput expectations, and regulatory considerations. Blood collection settings prioritize sample integrity and ease of phlebotomy workflows, insulin delivery emphasizes repeated home use and patient ergonomics, while vaccination campaigns demand high-volume deployment, ease of use by non-specialist staff, and storage robustness. End-user segmentation separates Clinics, Home Care, and Hospitals to reflect differing procurement processes, training intensity, and device lifecycle management needs. Devices destined for home care must balance simplicity and safety for lay users, whereas hospital procurement emphasizes integration with clinical systems and staff training.

Distribution channel segmentation spans Hospital Pharmacies, Online, and Retail Pharmacies, with Online further dissected into Company Websites and Third-Party Platforms to capture distinct buyer journeys and fulfillment arrangements. These distribution pathways shape time-to-market, pricing transparency, and after-sales support expectations. Understanding how these segmentation dimensions intersect enables clearer targeting and product positioning, revealing where clinical benefits, operational fit, and commercial viability converge to drive adoption.

Strategic regional analysis that explains how Americas, Europe Middle East & Africa, and Asia-Pacific markets differ in regulation, procurement, and adoption drivers

Regional dynamics play a pivotal role in shaping regulatory expectations, procurement behavior, and innovation diffusion across the safety needle market. In the Americas, health systems exhibit strong institutional purchasing frameworks and a high level of clinical governance, which prioritize devices that deliver clear demonstrable safety advantages and align with infection prevention programs. Procurement cycles can be influenced by public health initiatives and payer scrutiny, and suppliers often need robust clinical data to secure large institutional contracts.

In Europe, Middle East & Africa, regulatory landscapes vary substantially, producing a patchwork of approval pathways and reimbursement models that require tailored market entry strategies. Countries with centralized procurement may generate rapid uptake for compliant products, yet differing national standards and economic contexts demand flexible pricing and distribution approaches. Meanwhile, emerging markets across the region present opportunities for scaled deployments of cost-effective safety solutions but necessitate attention to local supply chain constraints and training capabilities.

Asia-Pacific demonstrates diverse adoption vectors, where advanced markets show fast uptake of user-friendly, technologically sophisticated devices while many markets remain focused on affordability and supply continuity. Rapidly expanding outpatient care and vaccination programs in the region elevate demand for scalable, easily deployable solutions. Across all regions, geopolitical developments and trade policies influence manufacturing location decisions and inventory strategies, underlining the importance of localized distribution networks and partnerships to maintain continuity of care.

Insightful examination of competitive dynamics, strategic partnerships, and capability priorities that determine which companies lead in safety needle innovation and supply reliability

Competitive dynamics within the safety needle sector emphasize continuous product improvement, regulatory compliance, and integrated service offerings. Market participants prioritize investments in human factors testing and clinical evidence generation to substantiate safety claims and differentiate in procurement processes that reward demonstrable outcomes. Collaboration between manufacturers and clinical partners has intensified, with co-development pilots and real-world evidence studies helping to accelerate acceptance among clinician stakeholders.

Supply chain reliability and scale capabilities also shape competitive positioning. Firms that can demonstrate redundant production capacity, validated quality systems, and responsive distribution networks earn preference from large institutional buyers who prioritize uninterrupted supply. At the same time, smaller, more agile companies carve niches by introducing novel activation mechanisms or lower-cost designs tailored to specific applications or geographies. Strategic partnerships, licensing agreements, and targeted acquisitions are common avenues to acquire complementary technology, expand geographic reach, or bolster manufacturing capabilities.

Across the industry, commercialization strategies increasingly emphasize total cost of ownership narratives, training and implementation support, and lifecycle services such as sharps disposal programs. These value-added services help buyers manage operational transition risks and support sustained adoption. Given regulatory scrutiny and procurement sophistication, companies that integrate clinical validation, manufacturing robustness, and service-oriented offerings position themselves to compete successfully for institutional and community-based contracts.

Practical and prioritized recommendations for manufacturers, distributors, and procurement leaders to accelerate adoption, reduce risk, and strengthen competitive advantage in safety needles

Industry leaders should adopt a multi-pronged strategic approach that aligns product development, supply resilience, and commercial engagement to capture emerging opportunities. First, prioritize human factors engineering and rigorous clinical validation early in the development cycle to create devices that demonstrably reduce needlestick risk while remaining intuitive for varied user populations. Investing in clinical studies and real-world evidence will materially strengthen procurement conversations and facilitate uptake in both institutional and community settings.

Second, reassess supply chain design to mitigate tariff exposure and geopolitical risk by diversifying sourcing, exploring nearshoring opportunities, and establishing contingency capacity. Suppliers and buyers alike should incorporate tariff sensitivity and supplier continuity metrics into procurement evaluations and contract terms. Third, develop go-to-market strategies that tailor value propositions to distinct end users: emphasize ease of use and patient-support programs for home care, workflow integration and staff training for hospitals, and cost-effectiveness and scalability for large vaccination initiatives.

Finally, expand commercial models to include training services, implementation support, and lifecycle management offerings that reduce adoption friction. Collaborate proactively with regulatory and procurement stakeholders to streamline approval pathways and align product labeling with clinical evidence. By combining validated safety performance, resilient supply strategies, and compelling service bundles, leaders can accelerate adoption and build durable competitive advantage.

Thorough explanation of the mixed-methods research approach combining primary interviews, documentary analysis, and triangulation to underpin the report's findings and conclusions

The research methodology combines primary and secondary data collection, structured expert interviews, and cross-validation techniques to ensure robust and actionable insights. Primary research included interviews with clinicians, procurement officers, and supply chain executives to capture firsthand perspectives on device performance, procurement criteria, and supply continuity challenges. These qualitative inputs informed hypothesis generation and the development of targeted follow-up queries to validate emerging themes.

Secondary research drew on regulatory filings, guidance documents, clinical literature, and company disclosures to establish a factual baseline for device categories, material considerations, and application-specific requirements. Data triangulation techniques reconciled differences across sources to minimize bias and increase confidence in conclusions. Where applicable, case studies and product performance summaries supplemented interview findings to illustrate real-world adoption patterns and implementation considerations.

Analytical rigor was maintained through transparent documentation of data sources, interview protocols, and assumptions used in comparative analyses. Limitations were acknowledged where data granularity varied across regions or end-user segments, and sensitivity checks were performed to assess how alternate interpretations could influence strategic implications. This mixed-methods approach ensures practical relevance for decision-makers while preserving methodological integrity and reproducibility.

Concise synthesis of principal findings that ties together clinical, supply chain, and commercial implications for stakeholders navigating the evolving safety needle environment

In conclusion, the safety needle landscape is being reshaped by a confluence of clinical priorities, regulatory scrutiny, distribution evolution, and supply chain realignments. As care models decentralize and patient-centered delivery expands, devices that combine reliable safety activation, user-centered design, and proven clinical outcomes will garner the strongest support from procurement and clinical stakeholders. At the same time, external forces such as tariff adjustments and geopolitical dynamics are driving strategic reassessments of manufacturing footprints and sourcing strategies.

Organizations that proactively invest in validated safety performance, resilient supply networks, and service-oriented commercialization models will be best positioned to navigate near-term disruptions and capture long-term opportunities. Cross-functional collaboration across clinical, regulatory, sourcing, and commercial teams will be essential to translate product innovation into sustained adoption. Ultimately, the market will favor solutions that demonstrably reduce risk, integrate smoothly into care workflows, and provide predictable supply continuity for diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Safety Needles Market, by Product Type

  • 8.1. Active
  • 8.2. Passive

9. Safety Needles Market, by Material

  • 9.1. Metal
  • 9.2. Plastic

10. Safety Needles Market, by Distribution Channel

  • 10.1. Hospital Pharmacies
  • 10.2. Online
    • 10.2.1. Company Websites
    • 10.2.2. Third-Party Platforms
  • 10.3. Retail Pharmacies

11. Safety Needles Market, by Application

  • 11.1. Blood Collection
  • 11.2. Insulin Delivery
  • 11.3. Vaccination

12. Safety Needles Market, by End User

  • 12.1. Clinics
  • 12.2. Home Care
  • 12.3. Hospitals

13. Safety Needles Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Safety Needles Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Safety Needles Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Safety Needles Market

17. China Safety Needles Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AdvaCare Pharma
  • 18.6. Argon Medical Devices, Inc.
  • 18.7. Artsana Group
  • 18.8. B. Braun SE
  • 18.9. Becton, Dickinson and Company
  • 18.10. Boston Scientific Corporation
  • 18.11. Cardinal Health, Inc.
  • 18.12. Cartel Healthcare Pvt. Ltd.
  • 18.13. Eli Lilly and Company
  • 18.14. Gerresheimer AG
  • 18.15. Hindustan Syringes and Medical Devices Ltd.
  • 18.16. Medtronic PLC
  • 18.17. Merit Medical Systems, Inc.
  • 18.18. Nanchang Kindly(KDL) Medical Technology Co., Ltd.
  • 18.19. Nipro Corporation
  • 18.20. Novo Nordisk A/S
  • 18.21. Retractable Technologies, Inc.
  • 18.22. Retrago Technologies
  • 18.23. Smiths Medical, Inc.
  • 18.24. Socorex Isba SA
  • 18.25. Sol-Millennium Medical Inc.
  • 18.26. Terumo Europe NV
  • 18.27. UltiMed, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SAFETY NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SAFETY NEEDLES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SAFETY NEEDLES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SAFETY NEEDLES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SAFETY NEEDLES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SAFETY NEEDLES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES SAFETY NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA SAFETY NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SAFETY NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SAFETY NEEDLES MARKET SIZE, BY ACTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SAFETY NEEDLES MARKET SIZE, BY ACTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SAFETY NEEDLES MARKET SIZE, BY ACTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SAFETY NEEDLES MARKET SIZE, BY PASSIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SAFETY NEEDLES MARKET SIZE, BY PASSIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SAFETY NEEDLES MARKET SIZE, BY PASSIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SAFETY NEEDLES MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SAFETY NEEDLES MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SAFETY NEEDLES MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SAFETY NEEDLES MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SAFETY NEEDLES MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SAFETY NEEDLES MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SAFETY NEEDLES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SAFETY NEEDLES MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SAFETY NEEDLES MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SAFETY NEEDLES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SAFETY NEEDLES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SAFETY NEEDLES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SAFETY NEEDLES MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SAFETY NEEDLES MARKET SIZE, BY COMPANY WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SAFETY NEEDLES MARKET SIZE, BY COMPANY WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SAFETY NEEDLES MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SAFETY NEEDLES MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SAFETY NEEDLES MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SAFETY NEEDLES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SAFETY NEEDLES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SAFETY NEEDLES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SAFETY NEEDLES MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SAFETY NEEDLES MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SAFETY NEEDLES MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SAFETY NEEDLES MARKET SIZE, BY INSULIN DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SAFETY NEEDLES MARKET SIZE, BY INSULIN DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SAFETY NEEDLES MARKET SIZE, BY INSULIN DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SAFETY NEEDLES MARKET SIZE, BY VACCINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SAFETY NEEDLES MARKET SIZE, BY VACCINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SAFETY NEEDLES MARKET SIZE, BY VACCINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SAFETY NEEDLES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SAFETY NEEDLES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SAFETY NEEDLES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SAFETY NEEDLES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SAFETY NEEDLES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SAFETY NEEDLES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SAFETY NEEDLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SAFETY NEEDLES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SAFETY NEEDLES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SAFETY NEEDLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS SAFETY NEEDLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA SAFETY NEEDLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SAFETY NEEDLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. GCC SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GCC SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. GCC SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. GCC SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. GCC SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 123. GCC SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. GCC SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. G7 SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. G7 SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. G7 SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. G7 SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. G7 SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 144. G7 SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. G7 SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. NATO SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. NATO SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. NATO SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. NATO SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. NATO SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 151. NATO SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. NATO SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES SAFETY NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA SAFETY NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)